Cargando…
Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study
BACKGROUND: Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify these associations. METHODS AND FINDINGS: Plasma phospholipid PUFAs were measured by gas chromatography among 12,132 inci...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951144/ https://www.ncbi.nlm.nih.gov/pubmed/27434045 http://dx.doi.org/10.1371/journal.pmed.1002094 |
_version_ | 1782443651002007552 |
---|---|
author | Forouhi, Nita G. Imamura, Fumiaki Sharp, Stephen J. Koulman, Albert Schulze, Matthias B. Zheng, Jusheng Ye, Zheng Sluijs, Ivonne Guevara, Marcela Huerta, José María Kröger, Janine Wang, Laura Yun Summerhill, Keith Griffin, Julian L. Feskens, Edith J. M. Affret, Aurélie Amiano, Pilar Boeing, Heiner Dow, Courtney Fagherazzi, Guy Franks, Paul W. Gonzalez, Carlos Kaaks, Rudolf Key, Timothy J. Khaw, Kay Tee Kühn, Tilman Mortensen, Lotte Maxild Nilsson, Peter M. Overvad, Kim Pala, Valeria Palli, Domenico Panico, Salvatore Quirós, J. Ramón Rodriguez-Barranco, Miguel Rolandsson, Olov Sacerdote, Carlotta Scalbert, Augustin Slimani, Nadia Spijkerman, Annemieke M. W. Tjonneland, Anne Tormo, Maria-Jose Tumino, Rosario van der A, Daphne L. van der Schouw, Yvonne T. Langenberg, Claudia Riboli, Elio Wareham, Nicholas J. |
author_facet | Forouhi, Nita G. Imamura, Fumiaki Sharp, Stephen J. Koulman, Albert Schulze, Matthias B. Zheng, Jusheng Ye, Zheng Sluijs, Ivonne Guevara, Marcela Huerta, José María Kröger, Janine Wang, Laura Yun Summerhill, Keith Griffin, Julian L. Feskens, Edith J. M. Affret, Aurélie Amiano, Pilar Boeing, Heiner Dow, Courtney Fagherazzi, Guy Franks, Paul W. Gonzalez, Carlos Kaaks, Rudolf Key, Timothy J. Khaw, Kay Tee Kühn, Tilman Mortensen, Lotte Maxild Nilsson, Peter M. Overvad, Kim Pala, Valeria Palli, Domenico Panico, Salvatore Quirós, J. Ramón Rodriguez-Barranco, Miguel Rolandsson, Olov Sacerdote, Carlotta Scalbert, Augustin Slimani, Nadia Spijkerman, Annemieke M. W. Tjonneland, Anne Tormo, Maria-Jose Tumino, Rosario van der A, Daphne L. van der Schouw, Yvonne T. Langenberg, Claudia Riboli, Elio Wareham, Nicholas J. |
author_sort | Forouhi, Nita G. |
collection | PubMed |
description | BACKGROUND: Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify these associations. METHODS AND FINDINGS: Plasma phospholipid PUFAs were measured by gas chromatography among 12,132 incident T2D cases and 15,919 subcohort participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct study across eight European countries. Country-specific hazard ratios (HRs) were estimated using Prentice-weighted Cox regression and pooled by random-effects meta-analysis. We also systematically reviewed published prospective studies on circulating PUFAs and T2D risk and pooled the quantitative evidence for comparison with results from EPIC-InterAct. In EPIC-InterAct, among long-chain n-3 PUFAs, α-linolenic acid (ALA) was inversely associated with T2D (HR per standard deviation [SD] 0.93; 95% CI 0.88–0.98), but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associated. Among n-6 PUFAs, linoleic acid (LA) (0.80; 95% CI 0.77–0.83) and eicosadienoic acid (EDA) (0.89; 95% CI 0.85–0.94) were inversely related, and arachidonic acid (AA) was not significantly associated, while significant positive associations were observed with γ-linolenic acid (GLA), dihomo-GLA, docosatetraenoic acid (DTA), and docosapentaenoic acid (n6-DPA), with HRs between 1.13 to 1.46 per SD. These findings from EPIC-InterAct were broadly similar to comparative findings from summary estimates from up to nine studies including between 71 to 2,499 T2D cases. Limitations included potential residual confounding and the inability to distinguish between dietary and metabolic influences on plasma phospholipid PUFAs. CONCLUSIONS: These large-scale findings suggest an important inverse association of circulating plant-origin n-3 PUFA (ALA) but no convincing association of marine-derived n3 PUFAs (EPA and DHA) with T2D. Moreover, they highlight that the most abundant n6-PUFA (LA) is inversely associated with T2D. The detection of associations with previously less well-investigated PUFAs points to the importance of considering individual fatty acids rather than focusing on fatty acid class. |
format | Online Article Text |
id | pubmed-4951144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-49511442016-08-08 Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study Forouhi, Nita G. Imamura, Fumiaki Sharp, Stephen J. Koulman, Albert Schulze, Matthias B. Zheng, Jusheng Ye, Zheng Sluijs, Ivonne Guevara, Marcela Huerta, José María Kröger, Janine Wang, Laura Yun Summerhill, Keith Griffin, Julian L. Feskens, Edith J. M. Affret, Aurélie Amiano, Pilar Boeing, Heiner Dow, Courtney Fagherazzi, Guy Franks, Paul W. Gonzalez, Carlos Kaaks, Rudolf Key, Timothy J. Khaw, Kay Tee Kühn, Tilman Mortensen, Lotte Maxild Nilsson, Peter M. Overvad, Kim Pala, Valeria Palli, Domenico Panico, Salvatore Quirós, J. Ramón Rodriguez-Barranco, Miguel Rolandsson, Olov Sacerdote, Carlotta Scalbert, Augustin Slimani, Nadia Spijkerman, Annemieke M. W. Tjonneland, Anne Tormo, Maria-Jose Tumino, Rosario van der A, Daphne L. van der Schouw, Yvonne T. Langenberg, Claudia Riboli, Elio Wareham, Nicholas J. PLoS Med Research Article BACKGROUND: Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify these associations. METHODS AND FINDINGS: Plasma phospholipid PUFAs were measured by gas chromatography among 12,132 incident T2D cases and 15,919 subcohort participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct study across eight European countries. Country-specific hazard ratios (HRs) were estimated using Prentice-weighted Cox regression and pooled by random-effects meta-analysis. We also systematically reviewed published prospective studies on circulating PUFAs and T2D risk and pooled the quantitative evidence for comparison with results from EPIC-InterAct. In EPIC-InterAct, among long-chain n-3 PUFAs, α-linolenic acid (ALA) was inversely associated with T2D (HR per standard deviation [SD] 0.93; 95% CI 0.88–0.98), but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associated. Among n-6 PUFAs, linoleic acid (LA) (0.80; 95% CI 0.77–0.83) and eicosadienoic acid (EDA) (0.89; 95% CI 0.85–0.94) were inversely related, and arachidonic acid (AA) was not significantly associated, while significant positive associations were observed with γ-linolenic acid (GLA), dihomo-GLA, docosatetraenoic acid (DTA), and docosapentaenoic acid (n6-DPA), with HRs between 1.13 to 1.46 per SD. These findings from EPIC-InterAct were broadly similar to comparative findings from summary estimates from up to nine studies including between 71 to 2,499 T2D cases. Limitations included potential residual confounding and the inability to distinguish between dietary and metabolic influences on plasma phospholipid PUFAs. CONCLUSIONS: These large-scale findings suggest an important inverse association of circulating plant-origin n-3 PUFA (ALA) but no convincing association of marine-derived n3 PUFAs (EPA and DHA) with T2D. Moreover, they highlight that the most abundant n6-PUFA (LA) is inversely associated with T2D. The detection of associations with previously less well-investigated PUFAs points to the importance of considering individual fatty acids rather than focusing on fatty acid class. Public Library of Science 2016-07-19 /pmc/articles/PMC4951144/ /pubmed/27434045 http://dx.doi.org/10.1371/journal.pmed.1002094 Text en © 2016 Forouhi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Forouhi, Nita G. Imamura, Fumiaki Sharp, Stephen J. Koulman, Albert Schulze, Matthias B. Zheng, Jusheng Ye, Zheng Sluijs, Ivonne Guevara, Marcela Huerta, José María Kröger, Janine Wang, Laura Yun Summerhill, Keith Griffin, Julian L. Feskens, Edith J. M. Affret, Aurélie Amiano, Pilar Boeing, Heiner Dow, Courtney Fagherazzi, Guy Franks, Paul W. Gonzalez, Carlos Kaaks, Rudolf Key, Timothy J. Khaw, Kay Tee Kühn, Tilman Mortensen, Lotte Maxild Nilsson, Peter M. Overvad, Kim Pala, Valeria Palli, Domenico Panico, Salvatore Quirós, J. Ramón Rodriguez-Barranco, Miguel Rolandsson, Olov Sacerdote, Carlotta Scalbert, Augustin Slimani, Nadia Spijkerman, Annemieke M. W. Tjonneland, Anne Tormo, Maria-Jose Tumino, Rosario van der A, Daphne L. van der Schouw, Yvonne T. Langenberg, Claudia Riboli, Elio Wareham, Nicholas J. Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study |
title | Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study |
title_full | Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study |
title_fullStr | Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study |
title_full_unstemmed | Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study |
title_short | Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study |
title_sort | association of plasma phospholipid n-3 and n-6 polyunsaturated fatty acids with type 2 diabetes: the epic-interact case-cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951144/ https://www.ncbi.nlm.nih.gov/pubmed/27434045 http://dx.doi.org/10.1371/journal.pmed.1002094 |
work_keys_str_mv | AT forouhinitag associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT imamurafumiaki associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT sharpstephenj associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT koulmanalbert associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT schulzematthiasb associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT zhengjusheng associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT yezheng associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT sluijsivonne associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT guevaramarcela associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT huertajosemaria associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT krogerjanine associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT wanglaurayun associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT summerhillkeith associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT griffinjulianl associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT feskensedithjm associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT affretaurelie associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT amianopilar associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT boeingheiner associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT dowcourtney associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT fagherazziguy associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT frankspaulw associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT gonzalezcarlos associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT kaaksrudolf associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT keytimothyj associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT khawkaytee associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT kuhntilman associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT mortensenlottemaxild associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT nilssonpeterm associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT overvadkim associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT palavaleria associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT pallidomenico associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT panicosalvatore associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT quirosjramon associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT rodriguezbarrancomiguel associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT rolandssonolov associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT sacerdotecarlotta associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT scalbertaugustin associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT slimaninadia associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT spijkermanannemiekemw associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT tjonnelandanne associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT tormomariajose associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT tuminorosario associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT vanderadaphnel associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT vanderschouwyvonnet associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT langenbergclaudia associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT ribolielio associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy AT warehamnicholasj associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy |